NL
DE
About Aurelius Therapeutics BV
Aurelius Therapeutics is bravely developing novel radioligand therapies (RLTs) comprising highly selective tumour-targeting molecules and potent tumour-killing radioisotopes.
read moreAbout Aurelius Therapeutics BV
Aurelius Therapeutics is bravely developing novel radioligand therapies (RLTs) comprising highly selective tumour-targeting molecules and potent tumour-killing radioisotopes. We are focused on areas of significant unmet need in oncology, particularly intractable solid tumours. Aurelius Therapeutics: Defend Patients, Defeat Cancer.
Aurelius Therapeutics BV details
- Affiliated department: Radiology and Nuclear medicine and Organic chemistry (RU)
- Researchers; Sandra Heskamp & James Nagarajah, Yvonne Derks and Dennis Löwik (RU)
- Year of incorporation: 2024
